| Application no. and date | 20151167.2 (espacenet) (Federated) (European Patent Register), 20160216 | | Patent/reg. no. and date | DK/EP 3673899, 20250625 | | Publication date | 20200701 | | Priority no. and date | US 201562117031 P, 20150217 | | EP pub. no. and date |
EP 3673899 20200701 | | Effective date | | | Applicant/owner | Amphastar Pharmaceuticals, Inc., 11570 Sixth Street
Rancho Cucamonga, CA 91730, US | | Applicant ref. no. | | | Inventor | MANTRIPRAGADA, Sankaram B., c/o Eli Lilly and Company
P. O. Box 6288
Indianapolis, Indiana 46206-6288, US,
Piche, Claude A, c/o Eli Lilly and Company
P.O Box 6288
Indianapolis, Indiana 46206-6288, US,
Van Betsbrugge, Jo Jan Filip, c/o Eli Lilly and Company
P.O Box 6288
Indianapolis, Indiana 46206-6288, US | | Representative | | | Opponent | | | IPC Class | A61K 31/724 (2006.01) , A61K 38/26 (2006.01) , A61K 45/06 (2006.01) , A61K 9/14 (2006.01) , A61P 3/00 (2006.01) , A61P 3/08 (2006.01) , A61P 43/00 (2006.01) , A61M 11/02 (2006.01) , A61M 15/08 (2006.01) | | Title | NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
